| Year |
Citation |
Score |
| 2022 |
Handorf EA, Smaldone MC, Movva S, Mitra N. Analysis of survival data with nonproportional hazards: A comparison of propensity-score-weighted methods. Biometrical Journal. Biometrische Zeitschrift. e202200099. PMID 36541715 DOI: 10.1002/bimj.202200099 |
0.492 |
|
| 2020 |
Madnick D, Handorf E, Ortiz A, Sorice K, Nagappan L, Moccia M, Cheema K, Vijayvergia N, Dotan E, Lynch SM. Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients. Journal of Gastrointestinal Oncology. 11: 633-643. PMID 32953147 DOI: 10.21037/Jgo-20-39 |
0.351 |
|
| 2020 |
Zimmaro LA, Deng M, Handorf E, Fang CY, Denlinger CS, Reese JB. Understanding benefit finding among patients with colorectal cancer: a longitudinal study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 32918129 DOI: 10.1007/S00520-020-05758-6 |
0.333 |
|
| 2020 |
Lynch SM, Handorf E, Sorice KA, Blackman E, Bealin L, Giri VN, Obeid E, Ragin C, Daly M. The effect of neighborhood social environment on prostate cancer development in black and white men at high risk for prostate cancer. Plos One. 15: e0237332. PMID 32790761 DOI: 10.1371/Journal.Pone.0237332 |
0.324 |
|
| 2020 |
Wong JK, Handorf E, Lee D, Jain R, Zhang E, Cooper HS, Farma JM, Dotan E, Meyer JE. Toxicity and outcomes in older versus younger patients treated with trimodality therapy for locally advanced rectal cancer. Journal of Geriatric Oncology. PMID 32381438 DOI: 10.1016/J.Jgo.2020.04.005 |
0.392 |
|
| 2020 |
Jain R, Handorf E, Khare V, Blau M, Chertock Y, Hall MJ. Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants. The Oncologist. 25: 161-169. PMID 32043776 DOI: 10.1634/Theoncologist.2019-0289 |
0.337 |
|
| 2020 |
Agrawal S, Meeker CR, Aggarwal S, Handorf EA, Adige S, Dotan E, Denlinger CS, Ward WH, Farma JM, Vijayvergia N. HSR20-076: Provider Versus Patient Reported Outcomes (PROs) in Colorectal Cancer (CRC) Patients (pts) Undergoing Systemic Therapy (Ctx): A Real World Experience Journal of the National Comprehensive Cancer Network. 18. DOI: 10.6004/Jnccn.2019.7503 |
0.37 |
|
| 2020 |
Lewis B, Meeker CR, Handorf E, Filchner K, Seedor R, Winn JS, Goldstein LJ, Dotan E. HSR20-093: Psychosocial Support in Older Patients With Metastatic Breast Cancer (MBC) Treated at Community Centers Journal of the National Comprehensive Cancer Network. 18. DOI: 10.6004/Jnccn.2019.7483 |
0.342 |
|
| 2020 |
Strother M, Kutikov A, Lewis B, Deng M, Handorf EA, Epstein M, Ghatalia P, Greenberg RE, Chen D, Viterbo R, Anari F, Smaldone MC, Zibelman MR, Uzzo RG, Plimack ER, et al. Neoadjuvant cisplatin-based chemotherapy in patients with ureteral obstruction secondary to muscle invasive bladder cancer. Journal of Clinical Oncology. 38: 523-523. DOI: 10.1200/Jco.2020.38.6_Suppl.523 |
0.378 |
|
| 2020 |
Walzer E, Deng M, Handorf EA, Blumenreich A, Pease L, Dorta M, Sorice K, Lynch SM, Vijayvergia N, Dotan E. Neoadjuvant therapy (NAT) and its role for pancreatic adenocarcinoma (PC) in the current era: Institutional experience. Journal of Clinical Oncology. 38: 672-672. DOI: 10.1200/Jco.2020.38.4_Suppl.672 |
0.305 |
|
| 2020 |
Winer A, Handorf EA, Dotan E. Gemcitabine and nab-paclitaxel in older adults with metastatic pancreatic cancer: Are two doses per cycle enough? Journal of Clinical Oncology. 38: 655-655. DOI: 10.1200/Jco.2020.38.4_Suppl.655 |
0.313 |
|
| 2020 |
Nakhoda S, Deng M, Iyer P, Handorf EA, Jain R, Meropol NJ, Dotan E. Assessing real-world biomarker testing rates in metastatic colon cancer. Journal of Clinical Oncology. 38: 209-209. DOI: 10.1200/Jco.2020.38.4_Suppl.209 |
0.336 |
|
| 2020 |
Iyer P, Whooley P, Handorf EA, Blau M, Chertock Y, Levin L, Hall MJ, Jain R. Associations between psoas muscle area (PMA) and density (PMD) with phase I oncology clinical trial outcomes. Journal of Clinical Oncology. 38: 7007-7007. DOI: 10.1200/Jco.2020.38.15_Suppl.7007 |
0.318 |
|
| 2020 |
Seedor RS, Meeker CR, Lewis B, Handorf EA, Filchner KA, Winn JS, Goldstein LJ, Dotan E. Prospective study comparing self-administered geriatric assessment to provider’s routine clinical assessment of older patients with metastatic breast cancer treated at community oncology practices. Journal of Clinical Oncology. 38: 12029-12029. DOI: 10.1200/Jco.2020.38.15_Suppl.12029 |
0.359 |
|
| 2020 |
Lynch SM, Yin Y, Handorf E. Abstract A03: Applying machine learning approaches to social environmental data from the U.S. Census in cancer studies: Challenges and considerations Cancer Epidemiology and Prevention Biomarkers. 29. DOI: 10.1158/1538-7755.Modpop19-A03 |
0.314 |
|
| 2020 |
Burbure N, Handorf E, Ridge JA, Liu J, Bauman J, Galloway TJ. Examining the roles of surgery and chemoradiation in hypopharynx cancer: a study of the National Cancer Database International Journal of Radiation Oncology Biology Physics. 106: 1147-1148. DOI: 10.1016/J.Ijrobp.2019.11.219 |
0.364 |
|
| 2019 |
Kadow BT, Joshi SS, Kutikov A, Handorf E, Smaldone MC, Uzzo RG, Geynisman DM. The volume-outcome relationship in kidney cancer: is more really better? Annals of Translational Medicine. 7: S336. PMID 32016054 DOI: 10.21037/Atm.2019.09.108 |
0.336 |
|
| 2019 |
Mateo AM, Mazor AM, Obeid E, Daly JM, Sigurdson ER, Handorf EA, DeMora L, Aggon AA, Bleicher RJ. Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes. Annals of Surgical Oncology. PMID 31712923 DOI: 10.1245/S10434-019-08050-Y |
0.334 |
|
| 2019 |
Ward WH, DeMora L, Handorf E, Sigurdson ER, Ross EA, Daly JM, Aggon AA, Bleicher RJ. Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer. Annals of Surgical Oncology. PMID 31562602 DOI: 10.1245/S10434-019-07844-4 |
0.362 |
|
| 2019 |
Ramamurthy C, Handorf EA, Correa AF, Beck JR, Geynisman DM. Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naïve prostate cancer. Urologic Oncology. PMID 31399302 DOI: 10.1016/J.Urolonc.2019.05.017 |
0.379 |
|
| 2019 |
Jain R, Yee JL, Shaikh T, Au C, Handorf E, Meyer JE, Dotan E. Treatment-related toxicity and outcomes in older versus younger patients with esophageal cancer treated with neoadjuvant chemoradiation. Journal of Geriatric Oncology. PMID 31257165 DOI: 10.1016/J.Jgo.2019.06.014 |
0.408 |
|
| 2019 |
Patel D, Handorf E, von Mehren M, Martin L, Movva S. Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage. Sarcoma. 2019: 3561501. PMID 30881199 DOI: 10.1155/2019/3561501 |
0.34 |
|
| 2019 |
Mateo AM, Mazor AM, DeMora L, Sigurdson ER, Handorf EA, Daly JM, Aggon AA, Obeid E, Hayes SB, Bleicher RJ. Patterns of Care and Efficacy of Chemotherapy and Radiotherapy in Skin-Involved Breast Cancers of All Sizes. Clinical Breast Cancer. PMID 30871966 DOI: 10.1016/J.Clbc.2019.02.003 |
0.343 |
|
| 2019 |
Reese JB, Lepore SJ, Daly MB, Handorf E, Sorice KA, Porter LS, Tulsky JA, Beach MC. A Brief Intervention to Enhance Breast Cancer Clinicians' Communication about Sexual Health: Feasibility, Acceptability, and Preliminary Outcomes. Psycho-Oncology. PMID 30811732 DOI: 10.1002/Pon.5036 |
0.311 |
|
| 2019 |
Dotan E, Handorf E, Meeker CR, Lewis B, Filchner K, Winn JS, Goldstein LJ. BPI19-011: Assessment and Management of Older Patients With Metastatic Breast Cancer (MBC) Among Community Oncologists in the United States Journal of the National Comprehensive Cancer Network. 17. DOI: 10.6004/Jnccn.2018.7193 |
0.322 |
|
| 2019 |
Joshi S, Handorf EA, Srivastava A, Masic S, Cahn DB, Kadow BT, Zibelman MR, Ghatalia P, Uzzo R, Kutikov A, Smaldone MC, Greenberg RE, Viterbo R, Chen D, Horwitz EM, et al. Treatment facility volume and survival in patients with advanced prostate cancer. Journal of Clinical Oncology. 37: 274-274. DOI: 10.1200/Jco.2019.37.7_Suppl.274 |
0.372 |
|
| 2019 |
O'Brien SB, Mutabdzic D, Handorf EA, Devarajan K, Reddy SS, Sigurdson ER, Denlinger CS, Meyer JE, Farma JM. Stage II and III rectal adenocarcinoma outcomes related to lymphovascular invasion. Journal of Clinical Oncology. 37: 698-698. DOI: 10.1200/Jco.2019.37.4_Suppl.698 |
0.397 |
|
| 2019 |
Mutabdzic D, O'Brien SB, Handorf EA, Devarajan K, Reddy SS, Sigurdson ER, Denlinger CS, Meyer JE, Farma JM. Evaluating the prognostic significance of lymphovascular invasion in stage II and III colon cancer. Journal of Clinical Oncology. 37: 685-685. DOI: 10.1200/Jco.2019.37.4_Suppl.685 |
0.328 |
|
| 2019 |
Ward WH, Meeker CR, Hill M, Handorf EA, Hall MJ, Sigurdson ER, Astsaturov IA, Denlinger CS, Reddy SS, Meyer JE, Zibelman MR, Madnick D, Moccia M, Dotan E, Farma JM, et al. Feasibility of using a fitness tracker to assess activity level and toxicity in colorectal cancer patients. Journal of Clinical Oncology. 37: 684-684. DOI: 10.1200/Jco.2019.37.4_Suppl.684 |
0.307 |
|
| 2019 |
Winer A, Handorf EA, Nagappan L, Blumenreich A, Chowdhury F, Vijayvergia N, Dotan E. Real world usage of gemcitabine and nabpaclitaxel in older adults with metastatic pancreatic cancer: A single institution experience. Journal of Clinical Oncology. 37: 358-358. DOI: 10.1200/Jco.2019.37.4_Suppl.358 |
0.349 |
|
| 2019 |
Madnick D, Sorice K, Yin Y, Handorf EA, Nagappan L, Moccia M, Cheema K, Vijayvergia N, Dotan E, Lynch SM. Investigating disparities: The effect of social environment on pancreatic cancer survival. Journal of Clinical Oncology. 37: 208-208. DOI: 10.1200/Jco.2019.37.4_Suppl.208 |
0.302 |
|
| 2019 |
Seedor RS, Savage MJ, Iqbal W, Arora S, Rainey K, Forman A, Lincoln S, Garcia J, Truty R, Esplin ED, Handorf EA, Hall MJ. The prevalence of hereditary pancreatitis mutations in families with pancreatic cancer. Journal of Clinical Oncology. 37: e15728-e15728. DOI: 10.1200/Jco.2019.37.15_Suppl.E15728 |
0.308 |
|
| 2019 |
Arora S, Demidova E, Avkshtol V, Lesh R, Browne AJ, Handorf EA, Golemis E, Meyer JE. Correlation of peripheral blood markers of DNA damage and immune response with chemoradiation response in patients with locally advanced rectal cancer. Journal of Clinical Oncology. 37: e15109-e15109. DOI: 10.1200/Jco.2019.37.15_Suppl.E15109 |
0.342 |
|
| 2019 |
Dotan E, Handorf E, Meeker CR, Lewis B, Flichner K, Winn JS, Goldstein LJ. Assessment And Management Of Older Patients With Metastatic Breast Cancer (Mbc) Among Community Oncologists In The United States Journal of Geriatric Oncology. 10. DOI: 10.1016/S1879-4068(19)31225-1 |
0.322 |
|
| 2019 |
Lee DY, Handorf E, Sigurdson ER, Denlinger C, Wong JK, Meyer JE. Response to Neoadjuvant Chemoradiation Increases with Age in Rectal Cancer Patients International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2149 |
0.362 |
|
| 2018 |
Churilla TM, Chowdhury IH, Handorf E, Collette L, Collette S, Dong Y, Alexander BM, Kocher M, Soffietti R, Claus EB, Weiss SE. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial. Jama Oncology. PMID 30419088 DOI: 10.1001/Jamaoncol.2018.4610 |
0.33 |
|
| 2018 |
Mazor AM, Mateo AM, Demora L, Sigurdson ER, Handorf E, Daly JM, Aggon AA, Anderson PR, Weiss SE, Bleicher RJ. Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database. Breast Cancer Research and Treatment. PMID 30343456 DOI: 10.1007/S10549-018-5007-4 |
0.332 |
|
| 2018 |
Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base. Cancer. 124: 3839-3848. PMID 30207380 DOI: 10.1002/Cncr.31582 |
0.329 |
|
| 2018 |
Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. American Journal of Clinical Oncology. PMID 29965809 DOI: 10.1097/Coc.0000000000000472 |
0.356 |
|
| 2018 |
Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis. European Urology. PMID 29880274 DOI: 10.1016/J.Eururo.2018.05.025 |
0.327 |
|
| 2018 |
Joshi SS, Handorf E, Strauss D, Correa AF, Kutikov A, Chen DYT, Viterbo R, Greenberg RE, Uzzo RG, Smaldone MC, Geynisman DM. Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis. Jama Oncology. PMID 29494739 DOI: 10.1001/Jamaoncol.2017.5608 |
0.358 |
|
| 2018 |
Churilla TM, DeMora L, Handorf E, Zaorsky NG, Dong Y, Denlinger CS, Sigurdson ER, Meyer JE. Deviations From Standard Chemoradiation Among Early-Stage Anal Cancer Patients. International Journal of Radiation Oncology, Biology, Physics. 100: 945-949. PMID 29485073 DOI: 10.1016/J.Ijrobp.2017.12.003 |
0.37 |
|
| 2018 |
Handorf EA, Heitjan DF, Bekelman JE, Mitra N. Estimating cost-effectiveness from claims and registry data with measured and unmeasured confounders. Statistical Methods in Medical Research. 962280218759137. PMID 29468944 DOI: 10.1177/0962280218759137 |
0.619 |
|
| 2018 |
Cahn DB, Handorf E, Edwards DC, Kidd L, Geynisman DM, Kadow BT, Greenberg RE, Viterbo R, Chen D, Kutikov A, Uzzo R, Smaldone MC. Treatment trends of localized renal cell carcinoma by hospital type: A NCDB analysis. Journal of Clinical Oncology. 36: 641-641. DOI: 10.1200/Jco.2018.36.6_Suppl.641 |
0.361 |
|
| 2018 |
Geynisman DM, Handorf E, Zibelman MR, Plimack ER, Uzzo R, Kutikov A, Smaldone MC. Treatment facility volume and survival in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology. 36: 594-594. DOI: 10.1200/Jco.2018.36.6_Suppl.594 |
0.358 |
|
| 2018 |
Judd J, Ramamurthy C, Handorf E, Borghaei H, Zibelman MR, Geynisman DM, Bauman JR. Response and adverse events to chemotherapy after prior checkpoint inhibition in lung cancer. Journal of Clinical Oncology. 36: 170-170. DOI: 10.1200/Jco.2018.36.5_Suppl.170 |
0.345 |
|
| 2018 |
Shulman RM, Avkshtol V, DeMora L, Esnaola NF, Hall MJ, Handorf E, Meyer JE. Microsatellite instability as a predictive marker for response to neoadjuvant chemoradiation in locally advanced rectal cancer. Journal of Clinical Oncology. 36: 806-806. DOI: 10.1200/Jco.2018.36.4_Suppl.806 |
0.372 |
|
| 2018 |
Jain R, Handorf E, Khare V, Blau M, Chertock Y, Clinton SK, Hall MJ. Prevalence and correlates of critical malnutrition (CMN) among gastrointestinal (GI) and non-GI participants in phase I/II (P1/2) clinical trials. Journal of Clinical Oncology. 36: 770-770. DOI: 10.1200/Jco.2018.36.4_Suppl.770 |
0.32 |
|
| 2018 |
Dotan E, Handorf EA, Meeker CR, Lewis B, Filchner KA, Winn JS, Goldstein LJ. The approach of community oncology providers towards pre-treatment assessment of older patients with metastatic breast cancer (MBC). Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E22043 |
0.322 |
|
| 2018 |
Galloway TJ, DeMora L, Handorf EA, Bleicher RJ, Sigurdson ER, Su S, Movva S, Horwitz EM, Smaldone MC, Jain A, Mantia-Smaldone G, Murphy CT, Ridge JA. Differential effects of increasing time to treatment initiation (TTI) for solid tumors. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E18520 |
0.347 |
|
| 2018 |
Mateo AM, Mazor AM, Obeid E, Sigurdson ER, DeMora L, Handorf EA, Daly JM, Aggon AA, Bleicher RJ. Time to surgery and the impact of delay on triple negative breast cancers and other phenotypes. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E12606 |
0.317 |
|
| 2018 |
Ramamurthy C, Correa AF, Handorf EA, Beck JR, Geynisman DM. Cost-effectiveness analysis of abiraterone acetate (AA) versus docetaxel (D) for the management of metastatic hormone naïve prostate cancer (mHNPC). Journal of Clinical Oncology. 36: 6514-6514. DOI: 10.1200/Jco.2018.36.15_Suppl.6514 |
0.326 |
|
| 2018 |
Hall MJ, Handorf EA, Forman A, Chertock Y, Obeid E, Daly MB. Feasibility of perioperative multi-gene panel testing (MGPT) in cancer patients eligible for hereditary genetic evaluation (GE): The PROTECT pilot. Journal of Clinical Oncology. 36: 1536-1536. DOI: 10.1200/Jco.2018.36.15_Suppl.1536 |
0.354 |
|
| 2018 |
Lynch SM, Handorf E, Newcomb C, Zeigler-Johnson C, Rebbeck TR. Abstract A03: Evaluating health disparities in prostate cancer: A neighborhood-wide association study (NWAS) in African Americans Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-A03 |
0.335 |
|
| 2018 |
Obeid E, Ellerbrock A, Handorf E, Goldstein L, Gatalica Z, Arguello D, Swain S, Isaacs C, Vacirca J, Tan A, Schwartzberg L. Abstract PD6-03: Distribution of microsatellite instability, tumor mutational load, and PD-L1 status in molecularly profiled invasive breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd6-03 |
0.326 |
|
| 2018 |
Cahn D, Handorf E, Edwards D, Kidd L, Geynisman D, Kadow B, Greenberg R, Viterbo R, Chen D, Kutikov A, Uzzo R, Smaldone M. Pd07-04 Treatment Trends Of Localized Renal Cell Carcinoma By Hospital Type: An Analysis Of The National Cancer Database The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.437 |
0.314 |
|
| 2018 |
Waingankar N, Smaldone M, Hallman M, Handorf E, Mehrazin R, Sfakianos J, Haseebuddin M, Viterbo R, Chen D, Greenberg R, Kutikov A, Ferket B, Galsky M, Mazumdar M, Uzzo R, et al. Mp51-01 Incremental Adherence To Guideline-Based Care Is Associated With Improved Survival Among Patients Who Undergo Bladder Preservation Therapy Or Radical Cystectomy For Muscle-Invasive Bladder Cancer The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1632 |
0.375 |
|
| 2018 |
Gauvin G, Lambreton F, Handorf E, Henry KA, Lynch SM, Farma JM. Cancer Screening Compliance and Incidence of Melanoma in Pennsylvania Journal of the American College of Surgeons. 227. DOI: 10.1016/J.Jamcollsurg.2018.08.576 |
0.33 |
|
| 2018 |
Wong JK, Handorf E, Jain R, Zhang E, Shaikh T, Dotan E, Meyer JE. An Analysis of Toxicity and Outcomes in Older Versus Younger Rectal Cancer Patients Treated with Trimodality Therapy International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.501 |
0.389 |
|
| 2018 |
Lee D, Handorf E, Churilla TM, Smaldone M, Hellstrom J, Waingankar N, Chen D, Hallman MA, Sobczak ML, Leachman BK, Horwitz EM. Acute and Subacute Complications of Brachytherapy for Prostate Cancer: A Single Institution Claims-Based Analysis International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.334 |
0.313 |
|
| 2018 |
Avkshtol V, Handorf E, Ridge JA, Liu JCJ, Bauman J, Galloway TJ. What Is the Benefit of Adjuvant Radiation Doses Above 60 Gy in Head and Neck Cancer Patients International Journal of Radiation Oncology Biology Physics. 100: 1337-1338. DOI: 10.1016/J.Ijrobp.2017.12.082 |
0.353 |
|
| 2017 |
Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival by Receipt of Lymph Node Dissection in Patients with Invasive Penile cancer: Results from the National Cancer Database. The Journal of Urology. PMID 29248557 DOI: 10.1016/J.Juro.2017.11.121 |
0.414 |
|
| 2017 |
Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. Jama Oncology. e173580. PMID 29121143 DOI: 10.1001/Jamaoncol.2017.3580 |
0.327 |
|
| 2017 |
Churilla TM, Handorf E, Collette S, Collette L, Dong Y, Aizer AA, Kocher M, Soffietti R, Alexander BM, Weiss SE. Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: 2588-2594. PMID 28961826 DOI: 10.1093/Annonc/Mdx332 |
0.308 |
|
| 2017 |
Cahn DB, Handorf E, Ristau BT, Geynisman DM, Simhan J, Kutikov A, Greenberg RE, Viterbo R, Chen DYT, Uzzo RG, Smaldone MC. Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: A National Cancer Database Analysis. Urologic Oncology. PMID 28803701 DOI: 10.1016/J.Urolonc.2017.07.026 |
0.397 |
|
| 2017 |
Cahn DB, Handorf EA, Ghiraldi EM, Ristau BT, Geynisman DM, Churilla TM, Horwitz EM, Sobczak ML, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG, Smaldone MC. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer. Cancer. PMID 28743162 DOI: 10.1002/Cncr.30900 |
0.373 |
|
| 2017 |
Wang LS, Handorf EA, Ridge JA, Burtness BA, Lango MN, Mehra R, Liu JC, Galloway TJ. Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification. Ear, Nose, & Throat Journal. 96: E12-E18. PMID 28719713 DOI: 10.1177/014556131709600703 |
0.322 |
|
| 2017 |
Cripe J, Handorf E, Brown J, Jain A, Rubin S, Mantia-Smaldone G. National Cancer Database Report of Lymphadenectomy Trends in Endometrial Cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 28525495 DOI: 10.1097/Igc.0000000000001005 |
0.342 |
|
| 2017 |
Shaikh T, Li T, Handorf EA, Johnson ME, Wang LS, Hallman MA, Greenberg RE, Price RA, Uzzo RG, Ma C, Chen D, Geynisman DM, Pollack A, Horwitz EM. Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 97: 722-731. PMID 28244407 DOI: 10.1016/J.Ijrobp.2016.12.034 |
0.351 |
|
| 2017 |
Heckman CJ, Handorf E, Darlow SD, Yaroch AL, Raivitch S. Refinement of measures to assess psychosocial constructs associated with skin cancer risk and protective behaviors of young adults Journal of Behavioral Medicine. 40: 574-582. PMID 28155000 DOI: 10.1007/S10865-017-9825-3 |
0.302 |
|
| 2017 |
Correa A, Handorf E, Joshi S, Ristau BT, Haifler M, Kutikov A, Greenberg RE, Chen D, Uzzo RG, Viterbo R, Geynisman DM, Smaldone MC. Neoadjuvant chemotherapy for elderly patients with locally advanced disease: Are we doing enough? Journal of Clinical Oncology. 35: 389-389. DOI: 10.1200/Jco.2017.35.6_Suppl.389 |
0.395 |
|
| 2017 |
Joshi S, Handorf E, Correa A, Kutikov A, Ristau BT, Haifler M, Viterbo R, Greenberg RE, Chen D, Uzzo RG, Geynisman DM, Smaldone MC. Systemic therapy and overall survival trends in patients with non-urothelial histologic variants of muscle invasive bladder cancer undergoing radical cystectomy. Journal of Clinical Oncology. 35: 376-376. DOI: 10.1200/Jco.2017.35.6_Suppl.376 |
0.415 |
|
| 2017 |
Nadler A, Handorf E, Sigurdson ER, Meyer JE, Denlinger CS, Farma JM. Neoadjuvant chemoradiation for locally advanced rectal cancer with fluoropyrimidine alone or intensified with oxaliplatin: A systematic review and meta-analysis. Journal of Clinical Oncology. 35: 678-678. DOI: 10.1200/Jco.2017.35.4_Suppl.678 |
0.383 |
|
| 2017 |
Shaikh T, Handorf E, Meyer JE, Hall MJ, Esnaola NF. Underuse of microsatellite instability testing and predictors of high microsatellite instability disease among young colorectal cancer patients. Journal of Clinical Oncology. 35: 534-534. DOI: 10.1200/Jco.2017.35.4_Suppl.534 |
0.366 |
|
| 2017 |
Jain R, Yee J, Shaikh T, Au C, Handorf E, Meyer JE, Dotan E. Toxicity and survival in older versus younger esophageal cancer (EC) patients (pts) treated with neoadjuvant chemoradiotherapy (nCRT). Journal of Clinical Oncology. 35: 204-204. DOI: 10.1200/Jco.2017.35.4_Suppl.204 |
0.354 |
|
| 2017 |
Jain R, Shaikh T, Yee J, Au C, Handorf E, Dotan E, Meyer JE. Association between markers of malnutrition (MN) and toxicity (T) during neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer (EC). Journal of Clinical Oncology. 35: 191-191. DOI: 10.1200/Jco.2017.35.4_Suppl.191 |
0.305 |
|
| 2017 |
Jain R, Handorf E, Khare V, Chertock Y, Hall MJ. Prevalence of critical malnutrition (CMN) in patients enrolling on phase I/II (P1/2) clinical trials. Journal of Clinical Oncology. 35: e21700-e21700. DOI: 10.1200/Jco.2017.35.15_Suppl.E21700 |
0.328 |
|
| 2017 |
Lynch SM, Handorf E, Blackman E, Bealin L, Daniel S, Giri VN, Obeid E, Ragin C, Daly MB. Abstract B01: Testing a multilevel risk prediction model in high risk men enrolled in a prostate cancer early detection program Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-B01 |
0.32 |
|
| 2017 |
Churilla T, Handorf E, Collette S, Collette L, Dong Y, Aizer A, Kocher M, Soffietti R, Alexander B, Weiss S. OS03.7 Does improved intracranial control from whole brain radiation therapy translate to improved overall survival in patients with limited competing risk from systemic disease? A secondary analysis of EORTC 22952–26001. Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox036.020 |
0.314 |
|
| 2017 |
Joshi S, Handorf E, Correa A, ristau B, Haifler M, Uzzo R, Greenberg R, Chen D, Viterbo R, Kutikov A, Geynisman D, Smaldone M. Mp10-19 Systemic Therapy And Overall Survival Trends In Patients With Non-Urothelial Histologic Variants Of Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.347 |
0.384 |
|
| 2017 |
Correa A, Handorf E, Ristau B, Haifler H, Joshi S, Uzzo R, Viterbo R, Greenberg R, Chen D, Kutikov A, Geynisman D, Smaldone M. Pd49-09 Survival Analysis Of Patients With T2 Penile Cancer Who Received Inguinal Lymph Node Dissection: Results From The National Cancer Database The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2233 |
0.36 |
|
| 2017 |
Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. The Effect of Increasing Biologically Effective Dose in Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer: A Meta-analysis International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1089 |
0.353 |
|
| 2017 |
Churilla TM, DeMora L, Handorf E, Zaorsky N, Dong Y, Denlinger C, Sigurdson E, Meyer J. S020) Are Early Stage Anal Cancer Patients Overtreated With Chemoradiotherapy International Journal of Radiation Oncology Biology Physics. 98. DOI: 10.1016/J.Ijrobp.2017.02.056 |
0.359 |
|
| 2016 |
Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: 967-975. PMID 27869097 DOI: 10.1016/J.Ijrobp.2016.08.046 |
0.383 |
|
| 2016 |
Smaldone MC, Egleston B, Hollingsworth JM, Hollenbeck BK, Miller DC, Morgan TM, Kim SP, Malhotra A, Handorf E, Wong YN, Uzzo RG, Kutikov A. Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data. Medical Care. PMID 27820596 DOI: 10.1097/Mlr.0000000000000657 |
0.305 |
|
| 2016 |
Bobrov E, Skobeleva N, Restifo D, Beglyarova N, Cai KQ, Handorf E, Campbell K, Proia DA, Khazak V, Golemis EA, Astsaturov I. Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models. Oncotarget. PMID 27779106 DOI: 10.18632/Oncotarget.12642 |
0.369 |
|
| 2016 |
Murphy CT, Handorf E, Sigurdson ER, Hayes SB, Anderson P, Weiss S, Shaikh T, Daly JM, Boraas M, Bleicher RJ. Assessment of National Practice Patterns of Radiation Therapy Use after Neoadjuvant Chemotherapy for Breast Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E51-E52. PMID 27674882 DOI: 10.1016/J.Ijrobp.2016.06.721 |
0.35 |
|
| 2016 |
Vijayvergia N, Boland PM, Handorf E, Gustafson KS, Gong Y, Cooper HS, Sheriff F, Astsaturov I, Cohen SJ, Engstrom PF. Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study. British Journal of Cancer. PMID 27482646 DOI: 10.1038/Bjc.2016.229 |
0.342 |
|
| 2016 |
Taylor NJ, Handorf EA, Mitra N, Avril MF, Azizi E, Bergman W, Bianchi-Scarrà G, Bishop DT, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, et al. Phenotypic and histopathological tumor characteristics according to CDKN2A mutation status among affected members of melanoma families. The Journal of Investigative Dermatology. PMID 26827760 DOI: 10.1016/J.Jid.2016.01.009 |
0.358 |
|
| 2016 |
Friedant AJ, Handorf EA, Su S, Scott WJ. Minimally Invasive versus Open Thymectomy for Thymic Malignancies: Systematic Review and Meta-Analysis. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: 30-8. PMID 26762737 DOI: 10.1016/J.Jtho.2015.08.004 |
0.326 |
|
| 2016 |
Waingankar N, Uzzo RG, Handorf E, Haseebuddin M, Corcoran A, Piotrowski Z, Smaldone MC, Kutikov A. Analytic morphometrics: Assessing the role of sarcopenia and abdominal fat measurements in predicting survival for mRCC patients undergoing cytoreductive nephrectomy. Journal of Clinical Oncology. 34: 603-603. DOI: 10.1200/Jco.2016.34.2_Suppl.603 |
0.319 |
|
| 2016 |
Ristau BT, Handorf E, Schaff M, Kim SP, Haseebuddin M, Waingankar N, Haifler M, Cahn D, Greenberg RE, Viterbo R, Chen DYT, Kutikov A, Uzzo RG, Smaldone MC. Contemporary utilization of non-surgical management for stage I renal masses. Journal of Clinical Oncology. 34: 564-564. DOI: 10.1200/Jco.2016.34.2_Suppl.564 |
0.373 |
|
| 2016 |
Haseebuddin M, Handorf E, Jones J, Kutikov A, Waingankar N, Ristau BT, Haifler M, Wong Y, Viterbo R, Greenberg RE, Uzzo RG, Chen DYT, Smaldone MC. Contemporary utilization trends of systemic chemotherapy for upper tract urothelial carcinoma (UTUC). Journal of Clinical Oncology. 34: 441-441. DOI: 10.1200/Jco.2016.34.2_Suppl.441 |
0.407 |
|
| 2016 |
Cahn D, Handorf E, Nordsiek M, Churilla TM, Horwitz EM, Ristau BT, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG, Smaldone MC. Contemporary utilization trends and survival outcomes in patients undergoing radical cystectomy and bladder preservation therapy for muscle invasive bladder cancer. Journal of Clinical Oncology. 34: 387-387. DOI: 10.1200/Jco.2016.34.2_Suppl.387 |
0.441 |
|
| 2016 |
Kaczmar JM, Handorf E, Woods J, Matro JM, Wong Y, Chertock Y, Daly MB, Hall MJ. Patient awareness and expectations of tumor genomic profiling (TGP) may predict willingness-to-pay (WTP) in a diverse patient sample. Journal of Clinical Oncology. 34: e13021-e13021. DOI: 10.1200/Jco.2016.34.15_Suppl.E13021 |
0.383 |
|
| 2016 |
Hall MJ, Hughes E, Handorf E, Gutin A, Allen B, Hartman A, Kurian AW. Magnitude of invasive breast cancer (BC) risk associated with mutations detected by multiple-gene germline sequencing in 95,561 women. Journal of Clinical Oncology. 34: 1512-1512. DOI: 10.1200/Jco.2016.34.15_Suppl.1512 |
0.311 |
|
| 2016 |
Brown JL, Handorf E, Cripe JC, Woodman S, Jain A, Rubin SC, Mantia-Smaldone GM. Widespread failure to adhere to National Comprehensive Cancer Network guidelines adversely impacts survival for patients with locally advanced cervical cancer Gynecologic Oncology. 141: 159-160. DOI: 10.1016/J.Ygyno.2016.04.416 |
0.391 |
|
| 2016 |
Cripe JC, Handorf E, Brown JL, Woodman S, Rubin SC, Jain A, Mantia-Smaldone GM. National Cancer Data Base report of associations, patterns, and survival benefit of lymphadenectomy in endometrial cancer Gynecologic Oncology. 141: 32-33. DOI: 10.1016/J.Ygyno.2016.04.107 |
0.394 |
|
| 2016 |
Cahn D, Handorf E, Nordsiek M, Churilla T, Horwitz E, Ristau B, Chen D, Vitebo R, Greenberg R, Kutikov A, Uzzo R, Smaldone M. Pd27-01 Contemporary Utilization Trends And Survival Outcomes In Patients Undergoing Radical Cystectomy And Bladder Preservation Therapy For Muscle Invasive Bladder Cancer The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.375 |
0.369 |
|
| 2016 |
Zaorsky NG, Handorf E, Horwitz EM, Hallman MA, Smaldone MC. Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 96. DOI: 10.1016/J.Ijrobp.2016.06.1327 |
0.35 |
|
| 2015 |
Geynisman DM, Handorf E, Wong YN, Doyle J, Plimack ER, Horwitz EM, Canter DJ, Uzzo RG, Kutikov A, Smaldone MC. Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma. Cancer Medicine. PMID 26679712 DOI: 10.1002/Cam4.577 |
0.36 |
|
| 2015 |
Li J, Handorf E, Bekelman J, Mitra N. Propensity score and doubly robust methods for estimating the effect of treatment on censored cost. Statistics in Medicine. PMID 26678242 DOI: 10.1002/Sim.6842 |
0.469 |
|
| 2015 |
Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26628469 DOI: 10.1200/Jco.2015.61.5906 |
0.355 |
|
| 2015 |
Shaikh T, Zaki MA, Dominello MM, Handorf E, Konski AA, Cohen SJ, Shields A, Philip P, Meyer JE. Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer. Acta Oncologica (Stockholm, Sweden). 1-6. PMID 26581671 DOI: 10.3109/0284186X.2015.1110252 |
0.379 |
|
| 2015 |
Movva S, von Mehren M, Ross EA, Handorf E. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 1366-74. PMID 26553766 DOI: 10.6004/Jnccn.2015.0165 |
0.371 |
|
| 2015 |
Shaikh T, Handorf EA, Murphy C, Kutikov A, Uzzo RG, Hallman M, Horwitz EM, Smaldone MC. Contemporary Trends in the Utilization of Radiotherapy in Patients with Renal Cell Carcinoma. Urology. PMID 26383611 DOI: 10.1016/J.Urology.2015.08.012 |
0.309 |
|
| 2015 |
Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SM, Polsky D, Armstrong K. Reply to G. Gandaglia et al and K. Lu. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2833. PMID 26215947 DOI: 10.1200/Jco.2015.62.4643 |
0.397 |
|
| 2015 |
Wang LS, Shaikh T, Handorf EA, Hoffman JP, Cohen SJ, Meyer JE. Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Practical Radiation Oncology. PMID 26077273 DOI: 10.1016/J.Prro.2015.04.004 |
0.315 |
|
| 2015 |
Xanthopoulos EP, Handorf E, Simone CB, Grover S, Fernandes AT, Sharma S, Corradetti MN, Evans TL, Langer CJ, Mitra N, Shah A, Apisarnthanarax S, Lin LL, Rengan R. Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study. Practical Radiation Oncology. 5: e355-63. PMID 25649540 DOI: 10.1016/J.Prro.2014.11.006 |
0.477 |
|
| 2015 |
Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K. Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 716-22. PMID 25559808 DOI: 10.1200/Jco.2014.57.2743 |
0.528 |
|
| 2015 |
Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder DB, Ridge JA. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database. Cancer. 121: 1204-13. PMID 25490875 DOI: 10.1002/Cncr.29191 |
0.367 |
|
| 2015 |
Smaldone MC, Handorf E, Kim SP, Thompson RH, Costello BA, Corcoran AT, Wong YN, Uzzo RG, Leibovich BC, Kutikov A, Boorjian SA. Temporal trends and factors associated with systemic therapy after cytoreductive nephrectomy: an analysis of the National Cancer Database. The Journal of Urology. 193: 1108-13. PMID 25444991 DOI: 10.1016/J.Juro.2014.10.095 |
0.376 |
|
| 2015 |
Corcoran AT, Handorf E, Canter D, Tomaszewski JJ, Bekelman JE, Kim SP, Uzzo RG, Kutikov A, Smaldone MC. Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type. Bju International. 115: 230-7. PMID 24447637 DOI: 10.1111/Bju.12638 |
0.31 |
|
| 2015 |
Haseebuddin M, Handorf E, Kutikov A, Waingankar N, Plimack ER, Uzzo RG, Smaldone MC. Rates of retroperitoneal lymph node dissection for stage I non-seminomatous germ cell tumors: Results from the National Cancer Database. Journal of Clinical Oncology. 33: 395-395. DOI: 10.1200/Jco.2015.33.7_Suppl.395 |
0.381 |
|
| 2015 |
Waingankar N, Handorf E, Smaldone MC, Plimack ER, Wong Y, Haseebuddin M, Horwitz EM, Uzzo RG, Kutikov A. The use of radiation for stage I seminoma: Analysis of the National Cancer Database. Journal of Clinical Oncology. 33: 385-385. DOI: 10.1200/Jco.2015.33.7_Suppl.385 |
0.408 |
|
| 2015 |
Haseebuddin M, Handorf E, Waingankar N, Wong Y, Viterbo R, Greenberg RE, Uzzo RG, Kutikov A, Smaldone MC, Chen DYT. Receipt of inguinal lymph node dissection in patients with T2 penile cancer: Results from the National Cancer Database. Journal of Clinical Oncology. 33: 383-383. DOI: 10.1200/Jco.2015.33.7_Suppl.383 |
0.377 |
|
| 2015 |
Wang LS, Handorf E, Murphy CT, Haseebuddin M, Waingankar N, Uzzo RG, Kutikov A, Bekelman JE, Horwitz EM, Smaldone MC. Contemporary trends in receipt of local therapy for men with clinically localized high-risk prostate cancer. Journal of Clinical Oncology. 33: 111-111. DOI: 10.1200/Jco.2015.33.7_Suppl.111 |
0.397 |
|
| 2015 |
Reddy SS, Handorf E, Smaldone MC, Ridge JA, Farma JM, Sigurdson ER. Trends of clinical staging for cancer patients at primary presentation: Have we improved over time? Journal of Clinical Oncology. 33: 737-737. DOI: 10.1200/Jco.2015.33.3_Suppl.737 |
0.387 |
|
| 2015 |
Wang LS, Hoffman JP, Handorf E, Murphy CT, Cooper HS, Cohen SJ, Meyer JE. Neoadjuvant chemoradiation (NACRT) and the prognostic effect of surgical margin (SM) status in pancreatic adenocarcinoma (PAC). Journal of Clinical Oncology. 33: 407-407. DOI: 10.1200/Jco.2015.33.3_Suppl.407 |
0.335 |
|
| 2015 |
Weston B, Shaikh T, Handorf E, Scott WJ, Cohen SJ, Meyer JE. Impact of sarcopenia (Sp) on outcomes in patients (pts) undergoing trimodality therapy for esophageal cancer. Journal of Clinical Oncology. 33: 221-221. DOI: 10.1200/Jco.2015.33.3_Suppl.221 |
0.369 |
|
| 2015 |
Shaikh T, Zaki MA, Dominello MM, Handorf E, Konski AA, Cohen SJ, Scott WJ, Meyer JE. Patterns of failure following tri-modality therapy for locally advanced esophageal cancer. Journal of Clinical Oncology. 33: 203-203. DOI: 10.1200/Jco.2015.33.3_Suppl.203 |
0.386 |
|
| 2015 |
Friedant AJ, Handorf E, Su S, Scott WJ. Systematic review and meta-analysis of the safety and efficacy of minimally invasive compared to open thymectomy for thymic malignancies. Journal of Clinical Oncology. 33: 6082-6082. DOI: 10.1200/Jco.2015.33.15_Suppl.6082 |
0.321 |
|
| 2015 |
Jain A, Handorf E, Mantia-Smaldone G. The use of adjuvant treatment in stage I endometrioid endometrial cancer in the National Cancer Database (NCDB). Journal of Clinical Oncology. 33: 5599-5599. DOI: 10.1200/Jco.2015.33.15_Suppl.5599 |
0.371 |
|
| 2015 |
Innocent J, Handorf E, Matro JM, Wong Y, Chertock Y, Daly MB, Hall MJ. Patient interest and willingness-to-pay (WTP) out-of-pocket (OOP) for comprehensive tumor genetic profiling (CGP). Journal of Clinical Oncology. 33: 1545-1545. DOI: 10.1200/Jco.2015.33.15_Suppl.1545 |
0.409 |
|
| 2015 |
Nicolas E, Zhou Y, Serebriiskii IG, Andrake MD, Handorf EA, Dunbrack RL, Giri VN, Ross EA, Golemis EA, Hall MJ, Daly MB. Abstract 537: Information-driven approaches to predicting familial risk for prostate cancer Cancer Research. 75: 537-537. DOI: 10.1158/1538-7445.Am2015-537 |
0.356 |
|
| 2015 |
Haseebuddin M, Handorf E, Kutikov A, Wainganker N, Wong Y, Plimack E, Uzzo R, Smaldone M. Pi-10 Declining Rates Of Retroperitoneal Lymph Node Dissection For Stage I Non-Seminomatous Germ Cell Tumors: Results From The National Cancer Database The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2909 |
0.314 |
|
| 2015 |
Waingankar N, Churilla T, Handorf E, Haseebuddin M, Tomaszewski J, Canter D, Kutikov A, Horwitz E, Greenberg R, Chen D, Viterbo R, Uzzo R, Smaldone M. Mp24-05 Treatment Delays In The Management Of Muscle Invasive Bladder Cancer: Analysis Of The National Cancer Database The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1147 |
0.374 |
|
| 2015 |
Haseebuddin M, Handorf E, Wainganker N, Viterbo R, Greenberg R, Uzzo R, Kutikov A, Smaldone M, Chen D. Mp24-03 Receipt Of Inguinal Lymph Node Dissection In Patients With T2 Penile Cancer: Results From The National Cancer Database The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1145 |
0.352 |
|
| 2015 |
Waingankar N, Handorf E, Smaldone M, Plimack E, Wong Y, Haseebuddin M, Horwitz E, Uzzo R, Kutikov A. Pd12-07 Decline In The Use Of Radiation For Stage I Seminoma: Analysis Of The National Cancer Database The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1059 |
0.319 |
|
| 2015 |
Haseebuddin M, Handorf E, Wong Y, Kim S, Wainganker N, Kutikov A, Bekelman J, Uzzo R, Smaldone M. Pd12-04 Trends In Utilization Of Primary Androgen Deprivation Therapy For Localized Prostate Cancer The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1056 |
0.316 |
|
| 2015 |
Murphy CT, Galloway TJ, Handorf E, Wang L, Mehra R, Flieder D, Ridge JA. Survival Impact of Increasing Time to Treatment Initiation for Head and Neck Cancer in the United States International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.309 |
0.348 |
|
| 2015 |
Wang L, Murphy CT, Handorf E, Freedman GM, Johnson ME, Shaikh T, Hayes SB, Bleicher RJ, Goldstein L, Anderson PR. Long-term Toxicity and Outcomes of Hypofractionated Radiation Therapy With an Incorporated Boost for Early-Stage Breast Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.142 |
0.342 |
|
| 2014 |
Corcoran AT, Kaffenberger SD, Clark PE, Walton J, Handorf E, Piotrowski Z, Tomaszewski JJ, Ginzburg S, Mehrazin R, Plimack E, Chen DY, Smaldone MC, Uzzo RG, Morgan TM, Kutikov A. Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy. Bju International. PMID 25123843 DOI: 10.1111/Bju.12897 |
0.329 |
|
| 2014 |
Johnson ME, Handorf EA, Martin JM, Hayes SB. Postmastectomy radiation therapy for T3N0: a SEER analysis. Cancer. 120: 3569-74. PMID 24985911 DOI: 10.1002/Cncr.28865 |
0.367 |
|
| 2014 |
Tomaszewski JJ, Handorf E, Corcoran AT, Wong YN, Mehrazin R, Bekelman JE, Canter D, Kutikov A, Chen DY, Uzzo RG, Smaldone MC. Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancer. The Journal of Urology. 192: 1349-54. PMID 24835054 DOI: 10.1016/J.Juro.2014.05.027 |
0.344 |
|
| 2014 |
Hall MJ, Herda MM, Handorf EA, Rybak CC, Keleher CA, Siemon M, Daly MB. Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 16: 854-61. PMID 24784156 DOI: 10.1038/Gim.2014.42 |
0.328 |
|
| 2014 |
Martin JM, Handorf EA, Kutikov A, Uzzo RG, Bekelman JE, Horwitz EM, Smaldone MC. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer. 120: 2114-21. PMID 24737481 DOI: 10.1002/Cncr.28697 |
0.356 |
|
| 2014 |
Handorf E, Crumpler N, Gross L, Giri VN. Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer. Journal of Genetic Counseling. 23: 371-6. PMID 24310616 DOI: 10.1007/S10897-013-9672-5 |
0.313 |
|
| 2014 |
Smaldone MC, Handorf E, Kim S, Thompson RH, Costello BA, Corcoran A, Wong Y, Uzzo RG, Leibovich BC, Kutikov A, Boorjian SA. Temporal trends and factors associated with receipt of systemic therapy among patients undergoing cytoreductive nephrectomy. Journal of Clinical Oncology. 32: 503-503. DOI: 10.1200/Jco.2014.32.4_Suppl.503 |
0.361 |
|
| 2014 |
Smaldone MC, Egleston B, Kim S, Handorf E, Geynisman DM, Wong Y, Uzzo RG, Kutikov A. Does nonsurgical management for localized kidney cancer equate to active surveillance in the SEER-Medicare population? Journal of Clinical Oncology. 32: 444-444. DOI: 10.1200/Jco.2014.32.4_Suppl.444 |
0.39 |
|
| 2014 |
Smaldone MC, Egleston B, Hollingsworth JM, Hollenbeck BK, Miller DC, Kim S, Handorf E, Wong Y, Uzzo RG, Kutikov A. Understanding treatment disconnect and mortality trends in renal cell carcinoma using tumor registry data. Journal of Clinical Oncology. 32: 403-403. DOI: 10.1200/Jco.2014.32.4_Suppl.403 |
0.33 |
|
| 2014 |
Tomaszewski JJ, Handorf E, Corcoran A, Mehrazin R, Canter D, Bekelman JE, Kutikov A, Chen DYT, Uzzo RG, Smaldone MC. Association of care transitions with treatment delay for patients with muscle-invasive bladder cancer. Journal of Clinical Oncology. 32: 346-346. DOI: 10.1200/Jco.2014.32.4_Suppl.346 |
0.366 |
|
| 2014 |
Jain A, Handorf E. Current practice and use of neoadjuvant therapy in ovarian cancer in the National Cancer Database. Journal of Clinical Oncology. 32: 5586-5586. DOI: 10.1200/Jco.2014.32.15_Suppl.5586 |
0.41 |
|
| 2014 |
Movva S, Handorf E, Ross EA, Mehren Mv. Patterns of chemotherapy administration in soft tissue sarcoma (STS) and impact on overall survival (OS): A National Cancer Database (NCDB) analysis. Journal of Clinical Oncology. 32: 10566-10566. DOI: 10.1200/Jco.2014.32.15_Suppl.10566 |
0.371 |
|
| 2014 |
Mehra R, Yang D, Handorf E, Serebriiskii I, Ross E, Lango M, Ridge JA, Golemis E, Burtness B. Abstract 4743: Analysis of a protein expression biomarkers in HPV negative SCCHN Cancer Research. 74: 4743-4743. DOI: 10.1158/1538-7445.Am2014-4743 |
0.318 |
|
| 2014 |
Tomaszewski J, Handorf E, Concodora C, Mehrazin R, Kutikov A, Viterbo R, Chen D, Greenberg R, Uzzo R, Smaldone M. Mp65-19 Performance Of Primary Radical Cystectomy And Risk Of Pathologic Upstaging In Patients With Stage I High Grade Urothelial Carcinoma Of The Bladder: A National Cancer Database Analysis The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1916 |
0.387 |
|
| 2014 |
Tomaszewski JJ, Uzzo RG, Egleston BL, Handorf E, Mehrazin R, Smaldone MC, Kutikov A. T1a Patients with Metastatic Renal Cell Cancer at Diagnosis Markedly Differ from Patients who Present with Localized Malignant Small Renal Mass (SRM) Journal of the American College of Surgeons. 219. DOI: 10.1016/J.Jamcollsurg.2014.07.361 |
0.327 |
|
| 2014 |
Shaikh T, Dominello MM, Zaki MA, Handorf E, Martin JM, Denlinger CS, Cohen SJ, Scott WJ, Konski AA, Meyer JE. Histology Predicts Response to Chemoradiation (cRT) Regimen in Patients Undergoing Esophagectomy for Locally Advanced Esophageal Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1137 |
0.384 |
|
| 2014 |
Martin JM, Handorf EA, Kutikov A, Uzzo RG, Bekelman JE, Horwitz EM, Smaldone MC. Utilization of Brachytherapy for the Treatment of Localized Prostate Cancer in the National Cancer Database Brachytherapy. 13. DOI: 10.1016/J.Brachy.2014.02.254 |
0.366 |
|
| 2013 |
Handorf EA, Bekelman JE, Heitjan DF, Mitra N. EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT. The Annals of Applied Statistics. 7: 2062-2080. PMID 24587844 DOI: 10.1214/13-Aoas665 |
0.628 |
|
| 2013 |
Bekelman JE, Handorf EA, Guzzo T, Evan Pollack C, Christodouleas J, Resnick MJ, Swisher-McClure S, Vaughn D, Ten Have T, Polsky D, Mitra N. Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 16: 610-8. PMID 23796296 DOI: 10.1016/J.Jval.2013.01.005 |
0.522 |
|
| 2013 |
Townsend NC, Handorf E, Lango M, Liu JC, Ridge JA, Veloski C, Galloway TJ. When do I Radiate? Age Implications for Differentiated Thyroid Cancer Management International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1218 |
0.301 |
|
| 2013 |
Bekelman J, Mitra N, Handorf E, Uzzo R, Hahn S, Polsky D, Armstrong K. Androgen-Deprivation Therapy and Radiation Therapy: Comparative Effectiveness in Real-World Clinical Practice International Journal of Radiation Oncology*Biology*Physics. 87: S40-S41. DOI: 10.1016/J.Ijrobp.2013.06.107 |
0.464 |
|
| 2012 |
Fernandes AT, Xanthopoulos E, Handorf E, Grover S, Sharma S, Eaby-Sandy B, Evans TL, Stevenson J, Langer CJ, Mitra N, Apisarnthanarax S, Lin L, Rengan R. Definitive thoracic radiotherapy in oligometastatic stage IV non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 30: e18032-e18032. DOI: 10.1200/Jco.2012.30.15_Suppl.E18032 |
0.521 |
|
| 2012 |
Bekelman J, Handorf E, Guzzo T, Christodouleas J, Resnick M, Swisher-McClure S, Vaughn D, Pollack C, Polsky D, Mitra N. Radical Cystectomy (RC) Versus Bladder Preservation Therapy (BPT) for Muscle-invasive Bladder Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S120-S121. DOI: 10.1016/J.Ijrobp.2012.07.213 |
0.518 |
|
| 2011 |
Armstrong K, Conant E, Chen J, Handorf E, Jones M, Boghossian L, Domchek SM. Incremental impact of breast cancer SNP panel on risk classification and screening. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1522. PMID 28024073 DOI: 10.1200/Jco.2011.29.15_Suppl.1522 |
0.311 |
|
| 2010 |
Roberts KE, Kawut SM, Krowka MJ, Brown RS, Trotter JF, Shah V, Peter I, Tighiouart H, Mitra N, Handorf E, Knowles JA, Zacks S, Fallon MB. Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology. 139: 130-9.e24. PMID 20346360 DOI: 10.1053/J.Gastro.2010.03.044 |
0.454 |
|
| Show low-probability matches. |